Amyloid β-peptides (Aβ) are a major hallmark of Alzheimer's disease (AD) and their neurotoxicity develop with cytosolic calcium dysregulation. On the other hand, calmodulin (CaM), a protein which plays a major multifunctional role in neuronal calcium signaling, has been shown to be involved in the regulation of non-amyloidogenic processing of amyloid β precursor protein (APP). Using fluorescent 6-bromoacetyl-2-dimethylaminonaphthalene derivatives of CaM, Badan-CaM, and human amyloid β(1-42) HiLyte™-Fluor555, we show in this work that Aβ binds with high affinity to CaM through the neurotoxic Aβ25-35 domain. In addition, the affinity of Aβ for calcium-saturated CaM conformation is approximately 20-fold higher than for CaM conformation in the absence of calcium (apoCaM). Moreover, the value of K d of 0.98±0.11 nM obtained for Aβ1-42 dissociation from CaM saturated by calcium point out that CaM is one of the cellular targets with highest affinity for neurotoxic Aβ peptides. A major functional consequence of Aβ-CaM interaction is that it slowdowns Aβ fibrillation. The novel and high affinity interaction between calmodulin and Aβ shown in this work opens a yet-unexplored gateway to further understand the neurotoxic effect of Aβ in different neural cells and also to address the potential of calmodulin and calmodulin-derived peptides as therapeutic agents in AD.
Introduction
A progressive loss of functional synapses has been noticed in hippocampal and cortical brain regions of patients with symptoms ranging from mild cognitive impairment (MCI) to early-mild Alzheimer's disease (AD) [1; 2] . The 42-residue-long amyloid β-peptide (Aβ1-42) is remarkably involved in AD. This peptide is prone to aggregation and also impairs synaptic function at both pre-and postsynaptic sites, although excitatory post-synapses are likely its early targets [3] . In addition, intracellular calcium homeostasis has been shown to be disrupted in both sporadic and familial forms of AD, and this can exacerbate Aβ formation and promote tau hyperphosphorylation [4; 5] . Dysregulation of intracellular Ca
2+
buffering by Aβ can trigger a pathogenic feed-forward cycle leading to an altered synaptic morphology, to neuronal apoptosis, and eventually to cognitive impairment [6] .
Calmodulin (CaM) plays a major role in neuronal calcium signaling, as a primary calcium binding protein relevant in cytosolic calcium buffering and also as a regulatory protein of other key effector proteins in calcium signaling pathways, reviewed in [7; 8; 9] . Noteworthy, nearly 30-years ago it was noticed that CaM is significantly decreased in the brain of AD individuals [10] . O'Day and Myre (2004) [11] raised the "calmodulin hypothesis" for late onset AD when they noticed that several proteins linked to the production of Aβ possess putative calmodulin binding domains (CaMBDs). However, the softwareaided prediction of proteins that bind to CaM is hindered by three major issues: (1) the large conformational change of CaM upon Ca 2+ binding [7; 8; 9] , (2) proteins do not bind to Ca 2+ /CaM via defined consensus targeting sequences, but through a diversity of motifs (e.g. 1-5-10 or 1-8-14 or 1-12 motifs or non-canonical motifs) involving hydrophobic amino acids and basic residues [12] , and (3) Ca 2+ -independent binding of proteins to CaM occurs via IQ-or IQ-like motifs showing certain degree of variability as well [8; 9] . Thus, direct experimental assessment of CaM interaction with each protein target is needed.
Actually, it has been shown that CaM can bind and regulate the functioning of both, amyloid β precursor protein (APP) and β-secretase (BACE1; beta-site APP cleaving enzyme 1) (reviewed in [9] ), as
well as one hallmark of AD such as tau [13] and also Ca 2+ /CaM-dependent protein kinase II (CaMKII) and cyclin-dependent kinase 5 (CDK5) involved in tau hyperphosphorylation [14] . Moreover, in a previous work [15] 
Materials and methods

Materials
All reagents and buffer components were of analytical grade purchased from Sigma-Aldrich (St.
Louis, MO), unless otherwise indicated. T34C and T110C variants of human expressed calmodulin were generated and labelled with Badan (6-Bromoacetyl-2-dimethylaminonaphthalene) in the same conditions as previously described for the T34C/T110C double mutant [16] . The labelled proteins were HPLC purified and freeze-dried. Unlabeled calmodulin from bovine testes was obtained from Sigma-Aldrich. Reconstituted peptides were aliquoted and stored at -20°C.
Fluorescence quenching studies
Fluorescence measurements were performed using a Cary Eclipse fluorescence spectrophotometer The fluorescence intensity data were corrected for volume changes during titrations, which were always <3%. No inner filter corrections were needed in titration data, because the increase of absorbance at excitation and emission wavelengths were always <0.002. Each experiment was performed in quadruplicate.
Calcium titration assays
For calcium titration assays 150 mM HEPES-KOH (pH 7.1), 100 mM KCl, 2mM MgCl 2 and 250 µM EGTA buffer was used. Afterwards, 10 nM of Badan-CaM(T110C) were added. To test the effect of β-amyloid peptides, Badan-CaM(T110C) was preincubated with either Aβ1-42 or Aβ25-35 at 37°C for 30 minutes at an equimolar ratio. Subsequently, CaCl 2 was added at increasing amounts and fluorescence was M A N U S C R I P T
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6 measured with an excitation wavelength of 385 nm and the fluorescence emission spectra were acquired from 400 nm to 650 nm, using a Cary Eclipse fluorescence spectrophotometer (Agilent Technologies).
Fluorescence measurements were performed at 25°C in 1 cm quartz cell with both excitation and emission slits of 10 nm. After subtracting the weak buffer fluorescence spectrum, the fluorescence emission spectra were corrected for volume changes. Each experiment was performed in quadruplicate.
Thioflavin T aggregation assays
The assay was performed as described in Maezawa et al. [17] . Briefly, a 35 µl of a 0.043 µM Aβ1-42 solution was mixed with 115 µl of Thioflavin T (ThT) solution (5 µM in 50 mM glycine-NaOH at pH 8.5) giving an Aβ1-42 final concentration of 10 µg/ml. When indicated, Aβ1-42 was previously aged at 37ºC for 72h, with or without the addition of CaM at equimolar ratio. After mixing with ThT, fluorescence emission at 490 nm, using an excitation wavelength of 440 nm [18] , was recorded by a
Varioskan Flash fluorescence spectrophotometer (Thermo Scientific).
Docking simulations
Modeling of protein-peptide interactions was performed using the CABS-dock web server (http://biocomp.chem.uw.edu.pl/CABSdock) [19; 20] . PDB files for both calmodulin conformations were obtained from Uniprot (http://www.uniprot.org/).
Statistical analysis
Non-linear regression fits, statistical analysis and plotting of titration data were done using OriginPro 8 software.
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Differences of Aβ1-42 fibrillation among treatments were assessed by analysis of variance with Turkey HSD (Honest Significant Difference) multiple comparison test using SigmaStat 3.10 (Systat).
Significant difference was accepted at the p<0.05 levels.
Results
To quantify and analyze the interaction between CaM and Aβ1-42 peptide, which is one of the 
Discussion
This work has demonstrated that neurotoxic Aβ peptides, Aβ1-42 and Aβ25-35, have a relatively high affinity for CaM with a calculated dissociation constant ≤1 nM for the Aβ/CaM complex at 25ºC, and physiological pH and ionic strength. This result showed that CaM is a novel intracellular high affinity target for Aβ because the concentration of non-fibrillar Aβ peptides is within the nanomolar range in the brain [21; 22; 23] . It is also to be recalled here that critical concentration values in the submicromolar range have been reported for induction of Aβ1-42 fibrillization [24; 25] . Moreover, the dissociation constant of Aβ-CaM complex obtained in this work indicates that the affinity of CaM for Aβ is approximately 20-fold higher than for human recombinant apo-E3 and -E4, a major risk factor for late onset Alzheimer's disease and also a well-accepted cellular target for Aβ with a dissociation constant value of 20 nM [26] . A binding affinity in the low nanomolar range has been calculated using surface plasmon resonance for Aβ1-42 interaction with the major intracellular target tau [27] . Noteworthy, the Aβ1-42 dissociation constant from Aβ-CaM complex is nearly identical to the reported dissociation constant of Aβ from PrP c [28] , a cellular prion protein that has been proposed to mediate Aβ-induced synaptic dysfunction in the mouse brain [25] , and also from glycogen synthase kinase 3α (GSK3α), a kinase that mediates hyperphosphorylation of tau and that it is stimulated in vitro by Aβ1-42 [29] . Docking simulations for Aβ25-35-apoCaM complex showed that most-probable docking conformations were completely different from those aforementioned for Ca 2+ saturation conditions ( Figure   4B ). Since apo-CaM has been reported to co-immunoprecipitate with APP, and to promote ADAM10-mediated proteolysis of APP through the non-amyloidogenic pathway resulting in sAPPα production [32] (thereby antagonizing the stimulation of BACE1-amyloidogenic pathway by CaM), binding of Aβ to apoCaM can be seen as a feed-back inhibition mechanism to modulate the production of neurotoxic Aβ peptides.
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In summary, this work shows a novel and high affinity interaction between calmodulin and the • Aβ binds with high affinity to calmodulin through the Aβ25-35 domain.
• Aβ has higher affinity for Ca 2+ -saturated calmodulin.
• Calmodulin is one of the cellular targets with highest affinity for Aβ.
• Aβ-Calmodulin interaction slows down Aβ fibrillation.
